Market cap
₹1 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
-5 %
-
ROCE
-4.7 %
-
Industry P/E
51.42
-
EV/EBITDA
-2.3
-
Debt to Equity
0.1
-
Book Value
₹--
-
EPS
₹-0.9
-
Face value
10
-
Shares outstanding
5,100,000
10 Years Aggregate
CFO
₹-3.49 Cr
EBITDA
₹-0.38 Cr
Net Profit
₹1.41 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sang Froid Labs (India)
| -- | -- | -- | 14.8 | -5.6 | -- | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
BSE Healthcare#
| 17.2 | 0.3 | 9.5 | 15.1 | 22.5 | 13.7 | 12.1 |
|
Company
|
2016
|
|---|---|
|
Sang Froid Labs (India)
| -92.1 |
|
BSE Sensex
| 1.9 |
|
BSE Healthcare
| -12.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sang Froid Labs (India)
|
1.3 | 0.7 | 0.0 | -0.4 | -- | -15.5 | -- | 0.3 |
| 332.8 | 5,266.9 | 1,113.6 | 114.0 | 13.8 | 12.8 | 46.3 | 5.9 | |
| 514.1 | 16,299.9 | 2,206.7 | 185.1 | 14.5 | 7.5 | 109.9 | 7.9 | |
| 700.2 | 10,463.1 | 2,627.4 | 31.6 | 8.5 | 12.2 | 459.3 | 7.8 | |
| 349.7 | 3,209.9 | 1,523.6 | 188.0 | 15.0 | 26.9 | 17.1 | 4.0 | |
| 286.5 | 9,387.4 | 1,557.8 | 187.8 | 16.1 | 12.8 | 50 | 5.9 | |
| 6,062.5 | 6,623.9 | 1,643.9 | 256.3 | 20.8 | 20.4 | 25.8 | 4.8 | |
| 286.3 | 12,340.3 | 1,393.6 | 213.2 | -- | 22.1 | 47.8 | 5.6 | |
| 1,447.2 | 14,675.4 | 1,820.1 | 290.3 | 22.9 | 18.1 | 51.4 | 8.6 | |
| 991.1 | 9,544.9 | 1,334.1 | 174.5 | 15.7 | 10.4 | 52.7 | 5.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Sang Froid Labs (India)
Manufacture of allopathic pharmaceutical preparations
-
Incorporated
1994
-
Chairman
--
-
Managing Director
--
-
Headquarters
Ahmedabad, Gujarat
-
Website
FAQs for Sang Froid Labs (India)
What is the current share price of Sang Froid Labs (India) Ltd Today?
The share price of Sang Froid Labs (India) Ltd is ₹1.32 (BSE) as of 25-Nov-2019 IST. Sang Froid Labs (India) Ltd has given a return of -5.62% in the last 3 years.
What is the current PB & PE ratio of Sang Froid Labs (India) Ltd?
Since, TTM earnings of Sang Froid Labs (India) Ltd is negative, P/E ratio is not available.
The P/B ratio of Sang Froid Labs (India) Ltd is 0.26 times as on 25-Nov-2019, a 96 discount to its peers’ median range of 7.05 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2018 |
0.00 |
0.18 |
2017 |
0.00 |
0.35 |
2016 |
2,889.66 |
1.39 |
2015 |
0.00 |
0.00 |
2014 |
0.00 |
0.00 |
What is the 52 Week High and Low of Sang Froid Labs (India) Ltd?
The 52-week high and low of Sang Froid Labs (India) Ltd are Rs -- and Rs -- as of 06-Sep-2026.
What is the market cap of Sang Froid Labs (India) Ltd?
Sang Froid Labs (India) Ltd has a market capitalisation of ₹ 1 Cr as on 25-Nov-2019. As per SEBI classification, it is a company.
Should I invest in Sang Froid Labs (India) Ltd?
Before investing in Sang Froid Labs (India) Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.